Skip to main content

Table 2 Multimorbidity prevalence according to disease group by country and gender among people aged 50 and over

From: Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over

 

Years

CM

95% CI

RE

95% CI

MS

95% CI

ND

95% CI

CA

95% CI

AAPC

Lower

Upper

AAPC

Lower

Upper

AAPC

Lower

Upper

AAPC

Lower

Upper

AAPC

Lower

Upper

Men

 Austria

2004–2017

0.6a

0.0

1.2

3.8a

1.7

5.9

1.3

−2.4

5.2

6.5

−5.0

19.4

0.2

−5.9

6.7

 Belgium

2004–2017

−2.0

−0.9

0.5

2.0a

0.8

3.2

3.7a

2.0

5.5

5.1

−5.4

16.8

−0.3

−4.6

4.2

 Czech Republic

2007–2017

0.6

−0.1

1.3

1.1

−2.7

5.1

6.3a

1.6

11.3

3.7

−8.4

17.5

−0.6

−4.5

3.6

 Denmark

2004–2017

0.6

−0.4

1.5

1.1

−0.9

3.2

−0.5

−1.3

0.4

2.1

−9.5

15.0

−4.6

−11.3

2.5

 Estonia

2011–2017

−1.7

−3.8

0.4

−6.8

−20.4

9.1

− 2.9

−15.1

11.1

7.1a

2.3

12.1

−4.4

− 18.0

11.4

 France

2004–2017

−0.5

−1.2

0.2

0.6

−2.2

3.5

2.3a

0.8

3.8

0.1

−8.9

10.1

−0.7

−3.0

1.8

 Germany

2004–2017

0.9a

0.1

1.6

4.1a

0.7

7.7

8.8a

6.0

11.7

0.7

−8.7

11.1

2.0

−2.9

7.1

 Netherlands

2004–2017

0.5

−1.5

2.5

4.1

−1.0

9.5

5.0

−6.7

18.1

1.0

−16.6

22.4

0.9

−10.9

14.4

 Italy

2004–2017

−0.3

−1.0

0.3

−5.0a

−7.4

−2.4

− 5.4a

−9.1

− 1.6

6.2

−2.0

15.1

− 1.0

−5.1

3.3

 Poland

2007–2017

0.4

−0.5

1.2

1.3

−0.5

3.2

0.1

− 1.9

2.1

−2.5

−11

6.9

4.7

−1.4

11.2

 Portugal

2011–2017

−1.4a

−2.3

−0.6

16.0a

12

20.2

−10.4a

−17.9

−2.2

−9.2

−27.7

14.0

−6.1

− 16.9

6.1

 Slovenia

2011–2017

0.0

−0.1

0.2

−1.7

− 12.9

11.0

5.0

−6.1

17.4

17.1a

5.7

29.6

−3.0

−15.6

11.4

 Spain

2004–2017

1.0a

0.3

1.6

−1.1

−3.7

1.7

−1.7

−4.2

0.9

6.8

−2.3

16.8

1.0

−4.8

7.2

 Sweden

2004–2017

−0.4

−1.0

0.2

2.7a

1.4

3.9

5.3a

1.1

9.7

1.5

−9.2

13.4

−4.2

−11.5

3.7

 Switzerland

2004–2017

−0.1

−0.9

0.8

2.3a

0.5

4.1

6.9a

4.2

9.7

3.5

−11.1

20.4

−2.7

−7.4

2.2

Women

 Austria

2004–2017

0.6a

0.0

1.2

3.5a

1.4

5.6

1.2

−2.5

5.1

6

−2.8

15.6

0.1

−6.1

6.7

 Belgium

2004–2017

−0.2

− 0.8

0.5

1.7a

0.6

2.8

3.5a

1.9

5.2

4.6

−3.2

13.1

−0.5

−4.8

4.1

 Czech Republic

2007–2017

0.5

−0.1

1.1

0.8

−2.9

4.6

6.0a

1.4

10.9

4.2

−5.1

14.5

−0.7

−4.8

3.6

 Denmark

2004–2017

0.5

−0.4

1.4

0.8

−1.1

2.8

−0.5

− 1.3

0.3

1.6

−7.4

11.4

−4.7

−11.3

2.3

 Estonia

2011–2017

−1.6

−3.4

0.2

−7.0

−20.2

8.5

−3.0

−14.6

10.2

7.0a

1.0

13.3

−4.7

−18.5

11.6

 France

2004–2017

− 0.5

−1.1

0.1

0.3

−2.4

3.1

2.2a

0.8

3.6

−0.3

−6.6

6.5

−0.8

−3.2

1.7

 Germany

2004–2017

0.8a

0.1

1.5

3.8a

0.4

7.3

8.5a

5.8

11.3

0.3

−6.6

7.8

1.8

−3.0

7.0

 Netherlands

2004–2017

0.4

−1.4

2.2

3.7

−1.3

9.0

4.9

−6.5

17.7

−0.4

−12.9

14.0

0.9

−10.9

14.1

 Italy

2004–2017

−0.3

− 0.9

0.3

− 5.2a

− 7.7

−2.7

− 5.4a

−9.0

−1.6

5.7a

0.0

11.7

−1.1

− 5.1

3.1

 Poland

2007–2017

0.3

− 0.6

1.2

1.0

−0.8

2.8

−0.1

−1.9

1.8

−1.9

−7.2

3.6

4.6

−1.5

11

 Portugal

2011–2017

−1.3a

−2.2

− 0.4

15.8a

12.1

19.6

−10.4a

−18

−2.0

− 9.0

− 28

15.2

−6.3

− 16.7

5.4

 Slovenia

2011–2017

0.1

−0.2

0.4

−1.8

−12.9

10.6

4.6

−6.4

17.0

17.1a

3.8

32.0

−3.2

−15.7

11.1

 Spain

2004–2017

0.9a

0.4

1.4

−1.4

− 4.0

1.3

−1.7

− 4.1

0.7

6.3a

0.0

13.0

0.9

−5.0

7.1

 Sweden

2004–2017

− 0.4

−1.0

0.2

2.3a

1.1

3.5

5.1a

1.0

9.4

1.1

−6.8

9.7

−4.3

−11.5

3.5

 Switzerland

2004–2017

−0.1

−0.8

0.7

2.0a

0.2

3.7

6.7a

4.0

9.5

3.1

−8.8

16.6

−2.8

−7.6

2.2

  1. aStatistically significant (p < 0.05); CM Cardiometabolic diseases, RE Respiratory diseases, MS Musculoskeletal diseases, ND Neurodegenerative diseases, CA Cancer